DEF: Tivic Health Systems Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
Proxy Statement
Tivic Health Systems is asking stockholders to approve a reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.
Summary
- Tivic Health Systems is holding a special meeting on January 31, 2025, to seek stockholder approval for a reverse stock split.
- The proposed reverse stock split would allow the board to combine outstanding shares at a ratio between 1-for-2 and 1-for-30.
- The primary reason for the reverse stock split is to meet Nasdaq's minimum $1.00 per share bid price requirement for continued listing.
- The company received a delisting notice from Nasdaq on December 27, 2024, and has appealed the decision.
- The board will determine the exact ratio within the approved range and has the option to abandon the split if deemed not in the best interest of the company.
- The reverse stock split will not change the total number of authorized shares or the par value of the stock.
- The company is also seeking approval to adjourn the special meeting if necessary to solicit additional proxies.
Sentiment
Score: 3
Explanation: The document indicates a negative situation with the company facing potential delisting from Nasdaq. While the reverse stock split is a measure to address this, it is not a positive development and carries risks.
Positives
- The reverse stock split is intended to help the company maintain its Nasdaq listing.
- The board has the flexibility to choose the most appropriate ratio for the reverse stock split within a specified range.
- The company is taking steps to appeal the delisting notice from Nasdaq.
- The reverse stock split will not change the terms of the common stock, voting rights, or dividend rights.
Negatives
- Reverse stock splits can be perceived negatively by investors.
- The stock price may not increase proportionally after the reverse stock split.
- The reverse stock split could reduce the liquidity of the stock.
- Some stockholders may end up with less than 100 shares, potentially increasing trading costs.
- There is no guarantee that the reverse stock split will prevent delisting from Nasdaq.
Risks
- The company's stock could be delisted from Nasdaq if the reverse stock split is not approved or if the company fails to meet listing requirements after the split.
- The reverse stock split may not increase the stock price or improve liquidity.
- The company's stock price could decline back to pre-reverse split levels.
- The increased number of authorized but unissued shares could have an anti-takeover effect.
Future Outlook
The company intends to implement the reverse stock split shortly after receiving stockholder approval to regain compliance with Nasdaq's minimum bid price requirement. The board has the discretion to abandon the reverse stock split if it is not in the best interest of the company.
Management Comments
- The Board has carefully reviewed and considered the foregoing proposals, and has concluded that each proposal is in the best interests of the Company and its stockholders.
- The Board believes that stockholder approval of a range of reverse split ratios from 1-for-2 to 1-for-30 is in the best interests of the Company and its stockholders.
Industry Context
Reverse stock splits are a common strategy for companies facing delisting from exchanges due to low stock prices. This action is often seen as a last resort to maintain listing status and potentially attract new investors.
Comparison to Industry Standards
- Many companies facing similar delisting notices from Nasdaq have implemented reverse stock splits to regain compliance, such as those in the biotechnology and small-cap technology sectors.
- The proposed range of 1-for-2 to 1-for-30 is within the typical range for reverse stock splits, which can vary widely depending on the company's specific circumstances and stock price.
- Companies like Cassava Sciences and Ocugen have recently undergone reverse stock splits to maintain their Nasdaq listings, with varying degrees of success in terms of subsequent stock performance.
Stakeholder Impact
- Shareholders will be impacted by the reverse stock split, which may affect the value and liquidity of their shares.
- The company's employees may be affected by the potential delisting and the company's efforts to regain compliance.
- The company's customers and suppliers may be indirectly affected by the company's financial situation and listing status.
Next Steps
- Stockholders will vote on the reverse stock split and adjournment proposals at the special meeting on January 31, 2025.
- The board will determine the specific ratio of the reverse stock split if approved by stockholders.
- The company will file an amendment to its charter with the Secretary of State of Delaware to effect the reverse stock split if approved.
- The company will notify stockholders of the reverse stock split implementation and provide instructions for exchanging stock certificates if necessary.
Key Dates
| Date | Description |
|---|---|
| December 20, 2024 | Record date for determining stockholders eligible to vote at the special meeting. |
| December 26, 2024 | Initial compliance date for Nasdaq's minimum bid price requirement. |
| December 27, 2024 | Date the company received a delisting notice from Nasdaq. |
| January 3, 2025 | Date the proxy materials were mailed to stockholders and the company filed an 8K disclosing the delisting notice. |
| January 7, 2025 | Date the company's securities were scheduled for suspension from Nasdaq, pending appeal. |
| January 31, 2025 | Date of the special meeting of stockholders. |
Keywords
reverse stock split, Nasdaq, delisting, stockholder meeting, minimum bid price, TIVC, proxy statement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.